Explore the connection between Alexithymia and personality disorders, including how difficulty identifying emotions can impact relationships and mental health. This post sheds light on emerging research and clinical insights to better understand emotional awareness in therapy.

Discover how alliance ruptures—breakdowns in the therapist-client relationship—affect the treatment of personality disorders. This post explores strategies for recognizing and repairing these ruptures to support more effective, long-term therapeutic outcomes.

New research shows that personality disorders may not be as stable as once thought. Learn how PD symptoms and diagnoses change over time—and what this means for treatment.

New research shows ketamine may help improve mood and functioning in Borderline Personality Disorder. Learn what this means for treatment options.

How personality traits and coping styles predict depression—Dr. Danish explains how these insights can guide better treatment beyond medications.

New research shows low-dose, short-course iron supplements are effective for kids and teens with anemia—crucial knowledge for psychiatric care.

New research shows low-dose, short-course iron supplements are effective for kids and teens with anemia—crucial knowledge for psychiatric care.

Many adults with personality disorders may actually meet criteria for high-functioning autism. Learn what the latest research reveals and how it impacts diagnosis and treatment.

AI is transforming mental health care by predicting recovery in generalized anxiety disorder (GAD). Learn how machine learning is shaping the future of GAD treatment at Philadelphia Integrative Psychiatry.

Daylight Saving Time affects sleep, mood, and heart health. Dr. Danish of Philadelphia Integrative Psychiatry explains the risks and how to adjust effectively.

Mindfulness can improve focus and reduce stress in ADHD. Discover how Philadelphia Integrative Psychiatry and Dr. Danish integrate mindfulness into ADHD care.

One of the medications our medication management team utilizes for patients with ADHD is Onyda X — a once-daily, non-stimulant liquid formulation approved for ADHD treatment in children aged six and older.

Originally developed as an antidepressant, amitriptyline has been found to be effective for multiple disorders beyond depression, including anxiety disorders, chronic pain, and sleep disturbances. By increasing levels of serotonin and norepinephrine in the brain, amitriptyline helps regulate mood, alleviate pain, and improve sleep quality.